May 8, 2013

Japanese drug maker Takeda Pharmaceutical Co. will buy Fort Collins, Colo.-based vaccine maker Inviragen for up to $250 million, the two companies said Wednesday.

May 7, 2013

Amid rapid growth over the last few years, Amber Pharmacy is more than doubling the size of its headquarters.

May 7, 2013

The outline of an exam that will be used to certify pharmacists working in the specialty channel has received approval from the Specialty Pharmacy Certification Board, the group said.

May 7, 2013

A Walgreens survey found that 37% of Medicare Part D beneficiaries have daily concerns about their prescription drug costs, and 1-in-5 say they’ve had to make sacrifices, such as delaying filling a prescription or skipping doses, to help manage medication costs.

May 7, 2013

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

May 6, 2013

Pfizer is attempting to stem the rise of counterfeit medicines by selling one of its most popular drugs — and one of the most popular targets for counterfeiters — online.

May 6, 2013

The Food and Drug Administration has approved a drug for HIV in infants and toddlers.

May 6, 2013

The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.

May 6, 2013

An experimental drug regimen under development by AbbVie could change the way hepatitis C is treated, according to a special designation it received from the Food and Drug Administration.

May 6, 2013

Florida's state legislature approved a bill last week that will allow pharmacists to substitute biosimilars for brand name biotech drugs.

May 6, 2013

Retail pharmacies, drug makers and law enforcement have a variety of methods used to fight organized crime, and the New Jersey Office of the Attorney General has drawn up a list of best practices that pharmacies can use to keep stores, drugs, staff and customers safe.

May 6, 2013

Pregnant women should not use migraine-prevention medications containing valproate sodium due to a higher risk of decreased IQ scores in children, the Food and Drug Administration warned.

May 6, 2013

Rite Aid is sending out a customized 38-ft. van to 50 stores around the country as part of a campaign to promote skin care.

May 6, 2013

Sam's Club is offering free skin and weight screenings during the weekend, the club retailer said Monday.

May 3, 2013

Actavis' had $1.9 billion in sales in first quarter 2013, the drug maker said.

May 3, 2013

Women who take low-dose oral contraceptives may be at increased risk of chronic pelvic-pain symptoms and pain during sexual climax, according to a new study.

May 3, 2013

Healthcare analytics firm IMS Health has acquired social media analytics company Semantelli Corp., saying the purchase would allow it to provide real-time monitoring and delivery of insights into consumer and physician behavior and sentiments.

May 3, 2013

Rates of testicular cancer among young men have risen significantly over the last two decades across racial and ethnic groups, according to a new study, and researchers are wondering what accounts for it.

May 2, 2013

Drug makers Boehringer Ingelheim and Eli Lilly have started a campaign designed to educate healthcare professionals about the role a type of protein plays in maintaining blood-sugar balance.

May 2, 2013

The Justice Department reported it will appeal a recent judicial decision that would require removing any age restriction from the purchase of the Plan B emergency contraceptive, according to a report published in USA Today.

May 2, 2013

The vast majority of mothers experience pain throughout their bodies, according to a new survey.

May 2, 2013

A company that manages pharmacy services for employer groups and health plans has selected a company founded by the National Community Pharmacists Association for its medication therapy management services.

May 1, 2013

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.